NEAA Venture Research Issues Update Report on Wound Management Technologies, Inc.

Description

NEAA Venture Research, LLC issued a report today on Wound Management Technologies, Inc. (WNDM: OTC QB) and upgraded their recommendation to “Speculative BUY” due to major announced sales contracts. According to Clay Mahaffey, CFA “WNDM recently announced a major multi-year distribution agreement that provides very significant sales over the next few years. This eliminates the question as to visibility of sales and provides a very important validation of the demand for their products; consequently we are upgrading our recommendation. In addition, most investors are unaware of the fact that the minimum sales targets in this agreement are about double our current year estimates so we are confident that sales will grow quickly over the next few years. We retain the $1.30 twelve month price target.”

WNDM

The free research report can be viewed at: http://neaaventure.com/wp-content/uploads/2011/07/WNDM_7.13.11.pdf

About NEAA Venture Research, LLC

NEAA Venture Research, LLC is an equity research company targeting selected smaller capitalization companies that we believe have growth potential but typically lack broker-dealer research coverage. Research services are provided on a subscription basis for institutional investors, broker-dealers, registered advisors and other investors. Research products include the VR 150 Index which is an index of 150 companies with market capitalization between $50 and $150 million, and the Micro Dynamic Portfolio which is a portfolio of twenty microcap companies.

Share: